Industry pressures on pharmaceutical companies are crushing right now. Payers are evaluating the drugs on their formularies constantly. Pay for performance in value-based care is just as critical to your therapies. Doctors are pressed for time with their patients and have their “go-to” drugs. At the same time, if a medication is perceived not to work, patients will stop taking it. In addition, the regulatory environment is pressing hard on pricing models to help patients afford their medications. And new market entry can be complicated further with an FDA REMS requirement.
The days of only focusing on product offerings are long gone. In addition to selling therapies, pharmaceutical companies need to find ways to manage patient health outcomes. That requires a partner that can help you get in front of doctors and patients to provide education, reduce prescription abandonment, offer financial support for patients, help you track efficacy and side effects, and alert providers to clinical research options.